282 related articles for article (PubMed ID: 18495396)
1. Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA.
Johnson HE; King SR; Banack SA; Webster C; Callanaupa WJ; Cox PA
J Ethnopharmacol; 2008 Jun; 118(1):159-65. PubMed ID: 18495396
[TBL] [Abstract][Full Text] [Related]
2. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z
Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166
[TBL] [Abstract][Full Text] [Related]
3. LC-MS/MS determination of the isomeric neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius.
Krüger T; Mönch B; Oppenhäuser S; Luckas B
Toxicon; 2010; 55(2-3):547-57. PubMed ID: 19825383
[TBL] [Abstract][Full Text] [Related]
4. Environmental neurotoxins β-N-methylamino-l-alanine (BMAA) and mercury in shark cartilage dietary supplements.
Mondo K; Broc Glover W; Murch SJ; Liu G; Cai Y; Davis DA; Mash DC
Food Chem Toxicol; 2014 Aug; 70():26-32. PubMed ID: 24755394
[TBL] [Abstract][Full Text] [Related]
5. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
Cox PA; Richer R; Metcalf JS; Banack SA; Codd GA; Bradley WG
Amyotroph Lateral Scler; 2009; 10 Suppl 2():109-17. PubMed ID: 19929742
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of matrix effects and performance of solid-phase extraction for LC-MS/MS analysis of β-N-methylamino-L-alanine (BMAA) and 2,4-diaminobutyric acid (DAB) neurotoxins in cyanobacteria.
Li A; Fan H; Ma F; McCarron P; Thomas K; Tang X; Quilliam MA
Analyst; 2012 Mar; 137(5):1210-9. PubMed ID: 22249403
[TBL] [Abstract][Full Text] [Related]
7. Previous studies underestimate BMAA concentrations in cycad flour.
Cheng R; Banack SA
Amyotroph Lateral Scler; 2009; 10 Suppl 2():41-3. PubMed ID: 19929730
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing the cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) from its structural isomer 2,4-diaminobutyric acid (2,4-DAB).
Banack SA; Downing TG; Spácil Z; Purdie EL; Metcalf JS; Downing S; Esterhuizen M; Codd GA; Cox PA
Toxicon; 2010 Nov; 56(6):868-79. PubMed ID: 20561540
[TBL] [Abstract][Full Text] [Related]
9. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Bradley WG; Mash DC
Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) from other diamino acids.
Banack SA; Metcalf JS; Spáčil Z; Downing TG; Downing S; Long A; Nunn PB; Cox PA
Toxicon; 2011 Apr; 57(5):730-8. PubMed ID: 21329717
[TBL] [Abstract][Full Text] [Related]
11. Detection of cyanobacterial neurotoxin β-N-methylamino-l-alanine within shellfish in the diet of an ALS patient in Florida.
Banack SA; Metcalf JS; Bradley WG; Cox PA
Toxicon; 2014 Nov; 90():167-73. PubMed ID: 25123936
[TBL] [Abstract][Full Text] [Related]
12. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
[TBL] [Abstract][Full Text] [Related]
13. Reversed-phase HPLC/FD method for the quantitative analysis of the neurotoxin BMAA (β-N-methylamino-L-alanine) in cyanobacteria.
Cianca RC; Baptista MS; Silva LP; Lopes VR; Vasconcelos VM
Toxicon; 2012 Mar; 59(3):379-84. PubMed ID: 22245623
[TBL] [Abstract][Full Text] [Related]
14. Determination of the neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (alpha-,gamma-diaminobutyric acid) by LC-MSMS in Dutch urban waters with cyanobacterial blooms.
Faassen EJ; Gillissen F; Zweers HA; Lürling M
Amyotroph Lateral Scler; 2009; 10 Suppl 2():79-84. PubMed ID: 19929738
[TBL] [Abstract][Full Text] [Related]
15. A Collaborative Evaluation of LC-MS/MS Based Methods for BMAA Analysis: Soluble Bound BMAA Found to Be an Important Fraction.
Faassen EJ; Antoniou MG; Beekman-Lukassen W; Blahova L; Chernova E; Christophoridis C; Combes A; Edwards C; Fastner J; Harmsen J; Hiskia A; Ilag LL; Kaloudis T; Lopicic S; Lürling M; Mazur-Marzec H; Meriluoto J; Porojan C; Viner-Mozzini Y; Zguna N
Mar Drugs; 2016 Feb; 14(3):. PubMed ID: 26938542
[TBL] [Abstract][Full Text] [Related]
16. Determination of the neurotoxin BMAA (beta-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry).
Rosén J; Hellenäs KE
Analyst; 2008 Dec; 133(12):1785-9. PubMed ID: 19082084
[TBL] [Abstract][Full Text] [Related]
17. Presence of the neurotoxic amino acids beta-N-methylamino-L-alanine (BMAA) and 2,4-diamino-butyric acid (DAB) in shallow springs from the Gobi Desert.
Craighead D; Metcalf JS; Banack SA; Amgalan L; Reynolds HV; Batmunkh M
Amyotroph Lateral Scler; 2009; 10 Suppl 2():96-100. PubMed ID: 19929740
[TBL] [Abstract][Full Text] [Related]
18. Co-occurrence of beta-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004.
Metcalf JS; Banack SA; Lindsay J; Morrison LF; Cox PA; Codd GA
Environ Microbiol; 2008 Mar; 10(3):702-8. PubMed ID: 18237305
[TBL] [Abstract][Full Text] [Related]
19. Beta-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates.
Esterhuizen M; Downing TG
Ecotoxicol Environ Saf; 2008 Oct; 71(2):309-13. PubMed ID: 18538391
[TBL] [Abstract][Full Text] [Related]
20. Effective determination method for a cyanobacterial neurotoxin, beta-N-methylamino-L-alanine.
Kubo T; Kato N; Hosoya K; Kaya K
Toxicon; 2008 Jun; 51(7):1264-8. PubMed ID: 18407310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
